Tag: chemosat
Delcath Systems announces publication of study comparing chemosaturation and SIRT
Delcath Systems, an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, have announced the publication of an...
Delcath Systems announces new drug application resubmission for Hepzato Kit
Delcath Systems has announced it has submitted a new drug application (NDA) resubmission to the US Food and Drug Administration (FDA) for the Hepzato...
Interventional News’ top 10 most popular stories of December 2022
Interventional News’ most popular stories as 2022 came to a close included news of a US Food and Drug Administration clearance for a new...
